RESUMEN
Spot lit: photocaged nucleic acids have been used to regulate gene expression through the action of light. Whereas most methods target mRNAs, DNA decoys have recently been used to target DNA transcription by targeting specific DNA-transcription-factor interactions. This has allowed researchers to "turn-off" transcription through the action of light on caged nucleic acids for the first time.
Asunto(s)
ADN/genética , Transcripción Genética/genética , ADN/química , ADN/metabolismo , ADN/efectos de la radiación , Luz , Procesos Fotoquímicos , Plásmidos/genética , Plásmidos/efectos de la radiaciónRESUMEN
Estrogen receptors (ERs) regulate gene transcription through classic estrogen response elements (EREs) as well as AP-1 responsive genes. The common SERMs Raloxifene, Tamoxifen, and ICI164384 function as ER antagonists on EREs but as ERbeta agonists/partial agonists on AP-1 responsive genes. While developing a mutant selective analog of Raloxifene, that is an antagonist of ERalpha(E353A), we discovered an antagonist of wild-type ERalpha and ERbeta that is also an antagonist of ERbeta/AP-1 response. The analog, DRL527, represses basal AP-1 gene expression and antagonizes Raloxifene stimulated AP-1 expression. Therefore DRL527 has a unique, previously unreported, ERE/AP-1 activity profile.
Asunto(s)
Moduladores de los Receptores de Estrógeno/farmacología , Receptores de Estrógenos/genética , Factor de Transcripción AP-1/genética , MutaciónRESUMEN
The nuclear hormone receptors are ligand-gated transcription factors that modulate gene expression by directly acting upon genomic DNA, and have been of profound interest across all biological disciplines. Recent advancements in this area have included the expansion of transgene activation through ligand-receptor engineering, drug development from structural design and the exploitation of innate ligand-specific associations towards developing novel conditional protein-based recombinant and diagnostic tools. These advancements come on the heels of exciting new modes of hormone action that challenge and expand upon the classic paradigms of hormone receptor function.
Asunto(s)
Receptores de Superficie Celular/metabolismo , Receptores Citoplasmáticos y Nucleares/metabolismo , Esteroides/química , Esteroides/metabolismo , Animales , ADN/genética , ADN/metabolismo , Diseño de Fármacos , Regulación de la Expresión Génica/genética , Regulación de la Expresión Génica/fisiología , Humanos , Ligandos , Modelos Biológicos , Modelos Moleculares , Receptores de Superficie Celular/química , Receptores Citoplasmáticos y Nucleares/química , Proteínas Recombinantes , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Transgenes/genética , Transgenes/fisiologíaRESUMEN
Molecular conjugates of hormone receptor-ligands with molecular probes or functional domains are finding diverse applications in chemical biology. Whereas many examples of hormone conjugates that target steroid hormone receptors have been reported, practical ligand conjugates that target the nuclear thyroid hormone receptor (TRbeta) are lacking. TR-targeting conjugate scaffolds based on the ligands GC-1 and NH-2 and the natural ligand triiodothyronine (T3) were synthesized and evaluated in vitro and in cellular assays. Whereas the T3 or GC-1 based conjugates did not bind TRbeta with high affinity, the NH-2 inspired fluorescein-conjugate JZ01 showed low nanomolar affinity for TRbeta and could be used as a nonradiometric probe for ligand binding. A related analogue JZ07 was a potent TR antagonist that is 13-fold selective for TRbeta over TRalpha. JZ01 localizes in the nuclei of TRbeta expressing cells and may serve as a prototype for other TR-targeting conjugates.
Asunto(s)
Amidas/síntesis química , Amidas/metabolismo , Compuestos de Bencilo/química , Fluoresceínas/química , Receptores de Hormona Tiroidea/metabolismo , Células 3T3 , Amidas/química , Animales , Compuestos de Bencilo/síntesis química , Fluoresceínas/síntesis química , Polarización de Fluorescencia , Colorantes Fluorescentes/síntesis química , Colorantes Fluorescentes/química , Colorantes Fluorescentes/metabolismo , Ligandos , Ratones , Unión Proteica , Receptores de Hormona Tiroidea/agonistas , Receptores de Hormona Tiroidea/antagonistas & inhibidores , Receptores alfa de Hormona Tiroidea/agonistas , Receptores alfa de Hormona Tiroidea/antagonistas & inhibidores , Receptores alfa de Hormona Tiroidea/metabolismo , Receptores beta de Hormona Tiroidea/agonistas , Receptores beta de Hormona Tiroidea/antagonistas & inhibidores , Receptores beta de Hormona Tiroidea/metabolismoRESUMEN
Three new Vitamin D analogs 3-5 incorporating a -CHF(2) group as an -OH surrogate have been prepared. Two of these new analogs (3 and 5) are strongly antiproliferative toward murine keratinocytes and are approximately 50 times less calciuric in vivo than the natural hormone calcitriol. The transcriptional activity of the 25-CHF(2) analog 3 is higher than that of the 1-CHF(2) analog 4.
Asunto(s)
Productos Biológicos/química , Productos Biológicos/farmacología , Diseño de Fármacos , Flúor/química , Hormonas/química , Vitamina D/análogos & derivados , Animales , Productos Biológicos/síntesis química , Calcio/orina , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Hormonas/síntesis química , Hormonas/farmacología , Metilación , Ratones , Estructura Molecular , Ratas , Vitamina D/síntesis química , Vitamina D/química , Vitamina D/farmacologíaRESUMEN
The Androgen Receptor (AR) remains the leading target of advanced prostate cancer therapies. Thiosalicylamide analogs have previously been shown to act in cells as acyltransfer catalysts that are capable of transferring cellular acetate, presumably from acetyl-CoA, to HIV NCp7. Here we explore if the cellular acetyl-transfer activity of thiosalicylamides can be redirected to other cellular targets guided by ligands for AR. We constructed conjugates of thiosalicylamides and the AR-binding small molecule tolfenamic acid, which binds the BF-3 site of AR, proximal to the coactivator "FXXLF" binding surface. The thiosalicylamide-tolfenamic acid conjugate, YZ03, but not the separate thiosalicylamide plus tolfenamic acid, significantly enhanced acetylation of endogenous AR in CWR22Rv1 cells. Further analysis confirms that Lys720, a residue critical to FXXLF coactivator peptide binding, is a site of acyl-YZ03 acetylation. Under acyl-transfer conditions, YZ03 significantly enhances the ability of BF-3 site binding ligands to inhibit AR-coactivator peptide association. These data suggest that biomimetic acyltransferases can enhance protein-protein interaction inhibitors through covalent modification of critical interfacial residues.
Asunto(s)
Aciltransferasas/metabolismo , Antagonistas de Andrógenos/farmacología , Biomimética , Receptores Androgénicos/efectos de los fármacos , Células HEK293 , HumanosRESUMEN
In some instances, small molecules can restore function to proteins that are impaired by genetic mutations. There are now many examples where non-specific molecules or specific ligands can act as chemical chaperones to fold proteins or stabilize folded proteins harboring genetic mutations. In contrast a few recent examples have shown that functionally impaired proteins that are stably folded can be "functionally rescued" by appropriate small molecules. Compounds that can rescue functionally impaired proteins may provide new strategies for the treatment of genetic diseases such as rickets and resistance to thyroid hormone (RTH). In addition mutant-complementing analogs and substrates that act exclusively on mutant proteins are providing important tools for the study of complex biological systems that are controlled by molecules that have multiple cellular targets.
Asunto(s)
Enfermedades Genéticas Congénitas/terapia , Ingeniería de Proteínas , Animales , Prueba de Complementación Genética , Humanos , Chaperonas Moleculares , Proteínas/genética , Proteínas/fisiologíaRESUMEN
The reengineering of protein-ligand (or enzyme-substrate) interfaces using a combination of chemical and genetic methods has become an increasingly common technique to create new tools to manipulate and study biological systems. Many applications of ligand receptor engineering require that the engineered ligand and receptor function independently of endogenous ligands and receptors. Engineered ligands must selectively interact with modified receptors, and modified receptors must effectively discriminate against endogenous ligands. A variety of chemical design strategies have been used to reengineer ligand-receptor interfaces. The advantages and limitations of various strategies, which involve the manipulation of hydrophobic, polar, and charged residues, are compared. New design strategies and potential applications of ligand-receptor engineering are also discussed.
Asunto(s)
Ingeniería de Proteínas , Receptores de Superficie Celular/química , Receptores de Superficie Celular/metabolismo , Transducción de Señal , Sitios de Unión , Diseño de Fármacos , Ligandos , Unión Proteica , Relación Estructura-Actividad , Especificidad por SustratoRESUMEN
[formula: see text] Vitamin D3-resistant rickets (VDRR) is associated with mutations to the Vitamin D receptor (VDR) which effect ligand-dependent transactivation. Some VDRR associated mutants directly disrupt ligand binding. Using the reported VDR-1,25-dihydroxy vitamin D3 (1,25(OH)2D3) cocrystal structure, three 1,25(OH)2D3 analogues were designed to uniquely complement the rickets associated mutant VDR(Arg274-->Leu). The three analogues were 17 to 286 times more potent than 1,25(OH)2D3 with the mutant in cell-based assays and did not substantially activate cellular calcium influx.
Asunto(s)
Colecalciferol/análogos & derivados , Receptores de Calcitriol/efectos de los fármacos , Raquitismo/tratamiento farmacológico , Calcio/metabolismo , Línea Celular , Diseño de Fármacos , Humanos , Ligandos , Modelos Moleculares , Mutación , Receptores de Calcitriol/genética , Raquitismo/genética , Relación Estructura-Actividad , Activación Transcripcional/efectos de los fármacosAsunto(s)
Carcinoma/genética , Neoplasias Hipofisarias/genética , Receptores beta de Hormona Tiroidea/química , Receptores beta de Hormona Tiroidea/genética , Triyodotironina/metabolismo , Secuencias de Aminoácidos , Sustitución de Aminoácidos , Carcinoma/metabolismo , Histidina/química , Histidina/genética , Humanos , Ligandos , Modelos Químicos , Mutación , Neoplasias Hipofisarias/metabolismo , Conformación Proteica , Receptores beta de Hormona Tiroidea/agonistas , Triyodotironina/farmacología , Tirosina/química , Tirosina/genéticaRESUMEN
Light-directed gene patterning methods have been described as a means to regulate gene expression in a spatially and temporally controlled manner. Several methods have been reported that use photocaged forms of small molecule effectors to control ligand-dependent transcription factors. Whereas these methods offer many advantages including high specificity and transient light-sensitivity, the free diffusion of the uncaged effector can limit both the magnitude and resolution of localized gene induction. Methods to date have been limited by the small fraction of irradiated cells that have expression levels significantly above uninduced background and have not been shown to affect a defined biological response. The tetracycline-dependent transactivator/transrepressor system, RetroTET-ART, combined with a photocaged form of doxycycline (NvOC-Dox) can be used to form photolithographic patterns of induced expression wherein up to 85% of the patterned cells show expression levels above uninduced regions. The efficiency and inducibility of the RetroTET-ART system allows one to quantitatively measure the limits of resolution and the relative induction levels mediated by a small molecule photocaged effector for the first time. Well-defined patterns of reporter genes were reproducibly formed within 6-36 h with feature sizes as small as 300 microm. After photo-patterning, NvOC-Dox can be rapidly removed, rendering cells photoinsensitive and allowing one to monitor GFP product formation in real time. Patterned co-expression of the cell surface ligand ephrin A5 on cell monolayers creates well-defined patterns that are sufficient to direct and segregate co-cultured cells via either attractive or repulsive signaling cues. The ability to direct the arrangement of cells on living cell monolayers through the action of light may serve as a model system for engineering artificial tissues.
Asunto(s)
Técnicas de Cocultivo/métodos , Regulación de la Expresión Génica/efectos de la radiación , Luz , Células 3T3 , Animales , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/genética , RatonesRESUMEN
While many research programs have focused on the challenge of developing small molecules that can inhibit protein-protein interactions, some researchers have taken the problem one step further by attempting to develop small molecules that mimic the essential features of an entire protein. An area of particular interest has been in the field of artificial transcription factors (ATFs), where the essential function of some transcription factors is to recruit and promote the assembly of a larger transcription complex, leading to the expression of a gene of interest. The goal of synthesizing small-molecule ATFs holds promise as a means to independently control the expression of genes such as those that are misregulated in cancer and disease.
Asunto(s)
Biomimética/métodos , Péptidos/síntesis química , Péptidos/metabolismo , Factores de Transcripción/síntesis química , Factores de Transcripción/metabolismo , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Humanos , Péptidos/química , Péptidos/genética , Ingeniería de Proteínas , Subunidades de Proteína/metabolismo , Factores de Transcripción/química , Transcripción GenéticaRESUMEN
Nuclear hormone receptors (NHRs) represent a diverse class of ligand-dependent transcriptional regulators. NHRs that have been rendered functionally inactive due to mutations that abrogate proper ligand binding can often be rescued by appropriately designed hormone analogues. The analogue-specific receptor-ligand pairs provide an ideal platform from which to develop new chemogenomic tools for the spatial and temporal control of gene expression. Here, we describe the synthesis and in vitro assessment of a photocaged VDR agonist specific to a mutant NHR that is associated with vitamin D-resistant rickets. The results provide insight into the utility of the agonist as a potential tool for photoinduced gene patterning.
Asunto(s)
Receptores de Calcitriol/agonistas , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , FotoquímicaRESUMEN
Nuclear receptors are ligand-dependent transcription factors that are of interest as potential tools to artificially regulate gene expression. Ligand binding induces a conformational change involving helix-12 which forms part of the dimerization interface used to bind transcriptional coactivators. When triiodothyronine (T3) binds the thyroid hormone receptor (TR) it indirectly contacts helix-12 through intermediary residues His(435) and Phe(451) termed a His-Phe switch. The mutant TRbeta(H435A) is nonresponsive to physiological concentrations of T3 but can be activated by the synthetic hormone analogue QH2 which potently activates His435-->Ala mutant at concentrations that do not activate the wild-type receptors TRalpha and TRbeta. QH2 does not show antagonist behavior with the wild-type TRs. QH2's functionally orthogonal behavior with TRbeta(H435A) is preserved on the three consensus thyroid hormone response elements.
Asunto(s)
Receptores de Hormona Tiroidea/química , Triyodotironina/química , Regulación Alostérica , Sitios de Unión , Ligandos , Modelos Moleculares , Estructura Molecular , Receptores de Hormona Tiroidea/efectos de los fármacos , Estereoisomerismo , Relación Estructura-Actividad , Triyodotironina/síntesis química , Triyodotironina/farmacologíaRESUMEN
We describe a novel fully automated high-throughput time-lapse microscopy system and evaluate its performance for precisely tracking the motility of several glioma and osteoblastic cell lines. Use of this system revealed cell motility behavior not discernable with conventional techniques by collecting data (1) from closely spaced time points (minutes), (2) over long periods (hours to days), (3) from multiple areas of interest, (4) in parallel under several different experimental conditions. Quantitation of true individual and average cell velocity and path length was obtained with high spatial and temporal resolution in "scratch" or "wound healing" assays. This revealed unique motility dynamics of drug-treated and adhesion molecule-transfected cells and, thus, this is a considerable improvement over current methods of measurement and analysis. Several fluorescent vital labeling methods commonly used for end-point analyses (GFP expression, DiO lipophilic dye, and Qtracker nanocrystals) were found to be useful for time-lapse studies under specific conditions that are described. To illustrate one application, fluorescently labeled tumor cells were seeded onto cell monolayers expressing ectopic adhesion molecules, and this resulted in consistently reduced tumor cell migration velocities. These highly quantitative time-lapse analysis methods will promote the creation of new cell motility assays and increase the resolution and accuracy of existing assays.
RESUMEN
The thyroid hormone receptors (TR) are ligand-dependant transcription factors that regulate key genes involved in metabolic regulation, thermogenesis and development. Resistance to thyroid hormone (RTH) is a genetic disease associated with mutations to TRbeta that lack or show reduced responsiveness to thyroid hormone (triiodothyronine). Previously we reported that the neutral alcohol-based thyromimetic HY-1 can selectively restore activity to a functionally impaired form of TR associated with RTH without over-stimulating TRalpha, which has been associated with undesirable side effects. Two new series of tetrazole and thiazolidinedione based ligands were evaluated for their ability to recover potency and efficacy to three of the most common RTH-associated mutants, TRbeta(R320C), TRbeta(R320H), and TRbeta(R316H), in cell based assays. A new thiazolidinedione based ligand AH-9 was identified, which has near wild-type potency (EC(50)=0.54 nM) to TRbeta(R320C) and TRbeta(R320H). Significantly, AH-9 is equipotent toward TRalpha(wt), TRbeta(wt), TRbeta(R320C), and TRbeta(R320H), suggesting that AH-9 may have the potential to restore the normal homeostatic balance of thyroid hormone actions in patients or models harboring these mutations.
Asunto(s)
Tiazoles/química , Síndrome de Resistencia a Hormonas Tiroideas/tratamiento farmacológico , Ligandos , Espectroscopía de Resonancia Magnética , Espectrometría de Masas , Mutación , Tiazoles/síntesis química , Tiazoles/metabolismo , Tiazoles/uso terapéuticoRESUMEN
Many genes elicit their actions through their expression in precise spatial patterns in tissues. Photoregulated expression systems offer a means to remotely pattern gene expression in tissues. Using currently available photopatterning methods, gene expression is only transient. Herein is described a general method to permanently alter a cell's genome under the control of light. The photocaged estrogen receptor (ER) antagonists, nitroveratryl-hydroxytamoxifen (Nv-HTam) and nitroveratryl-hydroxytamoxifen aziridine (Nv-HTaz), mediate exposure-dependent recombination in cells expressing the Cre-ER, a fusion of the site-specific recombinase Cre and ER. Both Nv-HTam and Nv-HTaz only activate recombination by Cre-ER after exposure to light. When released only intracellularly, the covalent-modifying Taz can mediate significant amounts of recombination in an exposure-dependent manner. Nv-HTaz and Cre-ER represent perhaps the first compound that can be used to photopattern gene expression through recombination.
Asunto(s)
Luz , Recombinación Genética , Tamoxifeno/análogos & derivados , Línea Celular , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Humanos , Estructura Molecular , Receptores de Estrógenos/efectos de los fármacos , Receptores de Estrógenos/metabolismo , Tamoxifeno/química , Tamoxifeno/farmacología , beta-Galactosidasa/efectos de los fármacos , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismoRESUMEN
The thyroid hormone receptors (TRs) are ligand-dependent transcription factors that control the expression of multiple genes involved in development and homeostasis in response to thyroid hormone (triiodothyronine, T3). Mutations to TRbeta that reduce or abolish ligand-dependent transactivation function are associated with resistance to thyroid hormone (RTH), an autosomal dominant human genetic disease. A series of neutral alcohol-based compounds, based on the halogen-free thyromimetic GC-1, have been designed, synthesized, and evaluated in cell-based assays for their ability to selectively rescue three of the most common RTH-associated mutations (i.e., Arg320 --> Cys, Arg320 --> His, and Arg316 --> His) that affect the basic carboxylate-binding arginine cluster of TRbeta. Several analogues show improved potency and activity in the mutant receptors relative to the parent compound GC-1. Most significantly, two of these mutant-complementing thyromimics show high potency and activity with a strong preference for the mutant receptors over wild-type TRalpha(wt), that is associated with the cardiotoxic actions of T3. The compounds were evaluated in reporter gene assays using the four common thyroid hormone response elements, DR4, PAL, F2 (LAP), and TSH, and show activities and selectivites consistent with their unique potential as agents to selectively rescue thyroid function to these RTH-associated mutants.
Asunto(s)
Resistencia a Medicamentos , Glicina/análogos & derivados , Imitación Molecular/genética , Mutagénesis Sitio-Dirigida , Receptores de Hormona Tiroidea/genética , Receptores de Hormona Tiroidea/metabolismo , Triyodotironina/farmacología , Acetatos/metabolismo , Arginina/genética , Arginina/metabolismo , Ácidos Carboxílicos/metabolismo , Línea Celular , Cisteína/genética , Resistencia a Medicamentos/genética , Glicina/química , Histidina/genética , Humanos , Ligandos , Fenoles/metabolismo , Regiones Promotoras Genéticas , Unión Proteica/genética , Secuencias Repetitivas de Ácidos Nucleicos , Elementos de Respuesta , Receptores beta de Hormona Tiroidea , Tirotropina/genética , Tirotropina/metabolismo , Tirotropina/farmacología , Triyodotironina/genética , Triyodotironina/metabolismoRESUMEN
Recently developed methods to regulate the spatial and temporal patterning of genes in a light-directed manner hold promise as powerful tools for exploring the function of genes that act through their unique spatiotemporal patterning. To further explore the application of photocaged ligands of nuclear receptors to control gene expression patterning, the actions of photocaged analogues of selective estrogen-receptor modulators (SERMs) have been evaluated. Photocaged derivatives of hydroxytamoxifen (NB-Htam) and guanidine tamoxifen (NB-Gtam) have been synthesized that selectively antagonize ER alpha- and ER beta-mediated transcription at classic estrogen response elements (EREs) in response to light. When present only intracellularly, Htam and Gtam provide a similar transient repression response. When SERMs are allowed to diffuse out of the cell, transcription is recovered at a similar rate for Htam and Gtam (6.4 and 5.6 h(-1)), but is notably faster than is observed with the covalently binding SERM tamoxifen aziridine (Taz) (3.8 h(-1)). This suggests that the duration of agonist action is controlled by ligand off-rates/diffusion and not by receptor turnover. Gtam activates ER beta-mediated transcription at AP1 sites in a similar way to what has previously been reported for Htam. NB-Gtam and NB-Tam provide a light-activated transcription response at AP1-driven reporters, thus illustrating the unique ability of photocaged SERMs to simultaneously mediate light-activated transcription and repression.
Asunto(s)
Silenciador del Gen/efectos de los fármacos , Luz , Moduladores Selectivos de los Receptores de Estrógeno/farmacología , Transcripción Genética/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Ligandos , Modelos Químicos , Fotólisis , Factores de TiempoRESUMEN
The reengineering of protein-small molecule interfaces represents a powerful tool of chemical biology. For many applications it is necessary to engineer receptors so that they do not interact with their endogenous ligands but are highly responsive to designed ligand analogues, which in turn do not interact with endogenous proteins. The chemical design strategy used to reengineer protein-small molecule interfaces is particularly challenging for interfaces involving relatively plastic receptor binding sites and therefore presents a unique challenge in molecular design. In this study we explore the scope and limitations of a new strategy for manipulating polar/charged residues across the ligand receptor interface of estradiol (E2) and the estrogen receptor (ER). Carboxylate-functionalized E2 analogues can activate ER alpha(Glu353-->Ala) and ER beta(Glu305-->Ala) with very large selectivites, demonstrating that this design strategy is extendable to other members of the steroid hormone receptor family. Neutral E2 analogues were found to complement ER alpha(E353A) with similar potencies but with generally lower selectivities. This suggests that the high selectivity observed with ligand-receptor pairs generated by exchanging charged residues across ligand-receptor interfaces is only due in part to their complementary shapes and that appropriate introduction of charged functionality on the ligand can provide substantial enhancement of selectivity by decreasing the engineered ligands affinity for the endogenous receptor. Attempts to modify the cationic residues by complementing Arg394-->Ala or Arg394-->Glu were not successful.